All Articles

RLJ Lodging Trust's stellar Q2 results weren't just a market beat; they were a validation of a shrewd strategy combining a lifestyle pivot with bold finance.

WM Technology's Q2 results show a puzzling split: higher net income but falling revenue and key metrics. Is this savvy cost-cutting or a sign of deeper trouble?

Morgan Stanley's lending arm maintains its dividend, but rising non-accruals and a NAV dip reveal the defensive maneuvers required in a cooling credit market.

A steep revenue drop and slashed guidance at Xponential Fitness raise urgent questions about its franchise model and whether the boutique fitness craze has hit a wall.

AIG's strong Q2 results beat profit estimates, powered by underwriting discipline as it completes its strategic pivot away from Corebridge Financial.

ESCO Technologies reports a stellar Q3 with 38% adjusted EPS growth and a record $1.5B backlog, proving its acquisition strategy is a powerful engine for growth.

The food-tech giant declared a routine dividend, but behind the curtain of record orders lies a significant asset writedown, raising questions about its health.

X4 Pharmaceuticals secures a key European approval and overhauls its pivotal trial, signaling a major strategic shift backed by a newly extended cash runway.

With record revenues and a raised outlook, Ryman Hospitality's Q2 results reveal more than just strong bookings—they map the future of group travel.

A 5% revenue dip masks a surge in users and a high-stakes bet on a new 'Predictions' product. Is DraftKings sacrificing a quarter to win the war?

Bimini Capital's strong Q2 results reveal a radical shift, trading its mortgage portfolio for asset manager TJIM, creating a new, more stable model.

Sunoco's acquisition of Offen Petroleum is more than a merger; it's a strategic consolidation reshaping the nation's energy backbone.

Clarus Corp. stunned with a Q2 profit, but a $6.1M tariff refund clouds the picture. As one segment soars and another sinks, a strategic review looms.

Beyond strong Q2 earnings, a forensic look at CBL's strategy reveals how aggressive debt restructuring and portfolio reinvention are creating a new model for retail.

Starling Oncology just hit positive Adjusted EBITDA, a milestone for its value-based care model. Is this the inflection point for profitability in oncology?

As Turkey’s multi-billion dollar dental tourism market booms, one Istanbul clinic is challenging the 'package deal' model, betting on clinical integrity.

Notessa's appointment of a dual-expert in law and real estate signals a major shift in how AI will conquer complex industries—by focusing on people, not platforms.

Despite a dip in legacy revenue, Autoscope Technologies posts higher profits and doubles down on AI solutions aimed at making cities smarter and safer for all.

Karat Packaging's profits surged 168% thanks to a massive one-time tariff refund. A deep dive reveals the real story lies in its strategic growth.

With its Duchenne therapy nearing a pivotal FDA meeting, Solid Biosciences isn't just developing a drug; it's building a network for genetic repair.